The rising patient base and improvements in the hemorrhoids diagnosis and treatment of hemorrhoids are the major factors driving the growth of the global hemorrhoids treatment market. Moreover, early hemorrhoids diagnosis is now possible with a rise in awareness about the problem and its cause. The ever-changing lifestyle and the increased adoption of sedentary habits along with less fibre food have been the major causes of the disorder. With this, there has been considerable advancement in the treatment of hemorrhoids. Newer drugs and advanced therapeutic machines are very useful in hemorrhoids diagnosis, hemorrhoids medications, and hermorrhoids self-care. Moreover, increases in public and private investments for infrastructure development are also fuelling the said market's growth.
Talking about the by-device segmentation of the said market, there are several devices which include, Band Ligators, Sclerotherapy Injectors, Infrared Coagulators, Bipolar Probes, Cryotherapy Devices, and Hemorrhoid Laser Probes. Out of these, Band ligators account for the major market share owing to their high efficiency. These devices are minimally invasive and show better long-term efficacy, which is why these devices have a substantial market share of the global hemorrhoids market. Moreover, these devices are highly cost-effective and the external hemorrhoids treatment procedure using band legator’s requires fewer sessions.
The topical agents occupy the major market share of the global hemorrhoids market due to their greater efficiency and quicker action. However, with advancements in drug development oral drugs are increasing their market share. Oral medications offer ease of administration and can be taken by individuals themselves without taking help from others, which is eventually aiding the external hemorrhoids treatment.
The treatment of hemorrhoids is done through drugs, non-surgical and surgical procedures, out of which the non-surgical procedures dominate the market. The development of effective drugs and therapeutic methods for hemorrhoids medications was successful in replacing surgical procedures. Band litigation has emerged as the most successful process and is commonly used nowadays.
Retail pharmacies are the largest segment by distribution channel of the global hemorrhoids treatment market. The vast network of retail pharmacies makes them close to patient customers. Moreover, easy access and buying procedures are growth-promoting factors for this segment. However, the online pharmacies segment is witnessing a higher growth rate owing to the increasing penetration of the internet.
Hospitals and Clinics dominate the end-user market segment of the hemorrhoids treatment market. These are the primary places of treatment for the majority of the population. Besides these better infrastructural facilities and professional support make them the leading segment.
The global hermorrhoids treatment market is primarily studied across four regions namely North America, Europe, Asia-Pacific and the Rest of the World. Out of these, the North American region is the largest regional market segment for the global hemorrhoids treatment market. The rising prevalence of hemorrhoids due to lifestyle changes and the adoption of sedentary habits is fueling the market growth in this region. According to research by NIDDK, 1 out of 20 Americans have hemorrhoids, and 10 million new cases appear each year. Moreover, well-developed healthcare infrastructure and active government support will further boost market growth in the North American region.
The European region is the second-largest segment in terms of revenue generation in the global hemorrhoids treatment market. The rising geriatric population and prevalence of lifestyle disorders are generating demand for external hemorrhoids treatment. Apart from this, well-developed medical infrastructure and active medical research backup are positive market factors in this segment.
The Asia-Pacific region is the fastest-growing market segment in the said market segment globally. The rapid development of healthcare infrastructure and the growth of the pharmaceutical industry are driving the market growth in this region. Moreover, the number of patient falls is also increasing with the increase in awareness about the disorder.
Intended Audience
This report will be beneficial for every stakeholder of the hemorrhoids treatment market such as :
Report Overview
This report provides an in-depth analysis of the hemorrhoids treatment market in terms of current value and future forecast. It has details about the problems and prospects of the given market. Moreover, the technological analysis section of this report will help in knowing the product better and its market prospects. Furthermore, this report contains a comprehensive analysis of every segment of the given market for the current forecast period (2024-2030). This report has also highlighted the key players and the current developments in the hemorrhoids treatment market.
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Report Attribute/Metric | Details |
| Market Size | USD 9.3 Billion (By 2032) |
| CAGR | 7.54% |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Treatment type, Route of administration, Distribution channel |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, Boston Scientific Corporation, CONMED Corporation, Cook Medical, GlaxoSmithKline, Olympus Corporation, Pfizer Inc., Takeda Pharmaceutical Company, Taro pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd, Astra Zeneca, Glenmark Pharmaceuticals |
| Key Market Opportunities | Medical treatment such as surgery, medication etc. |
| Key Market Drivers | Rapidly improving technology, and the presence of huge patient pool drive the growth of this market in Asia Pacific Region |
Hemorrhoids Treatment Market Highlights:
Frequently Asked Questions (FAQ) :
The Global Hemorrhoids Treatment Market is studied from 2024-2032.
The Global Hemorrhoids Treatment Market is growing at a CAGR of 7.54% during 2024-2032.
Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, Boston Scientific Corporation, CONMED Corporation, Cook Medical, GlaxoSmithKline, Olympus Corporation, Pfizer Inc., Takeda Pharmaceutical Company, Taro pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd, Astra Zeneca, Glenmark Pharmaceuticals are the major companies operating in Global Hemorrhoids Treatment Market.
Rapidly improving technology, and the presence of huge patient pool are the factors expected to propel the growth of the global Hemorrhoids Treatment market
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
